[Asia Economy Reporter Oh Ju-yeon] SK subsidiary SK Biopharmaceuticals announced on the 21st that the new drug for sleep disorder treatment (Solriamfetol, product name: Sumosi (Sunosi)) licensed to Jazz Pharmaceuticals has received marketing authorization from the European Medicines Agency (EMA).
© The Asia Business Daily(www.asiae.co.kr). All rights reserved.
![Clutching a Stolen Dior Bag, Saying "I Hate Being Poor but Real"... The Grotesque Con of a "Human Knockoff" [Slate]](https://cwcontent.asiae.co.kr/asiaresize/183/2026021902243444107_1771435474.jpg)
